Skip to content
Bored Studies
RecruitingAccepts healthy volunteersPhase 4

Intraperitoneal Infusion of Analgesic for Postoperative Pain Management

Ying Liu · with Avanos Medical · NCT04130464

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–65 · Women only
Healthy volunteers
Accepted
Study type
Interventional · Phase 4
Target enrollment
120
US sites recruiting
2
Study start
September 30, 2019
Record last updated
April 9, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The study is a prospective, double-blinded, placebo-controlled multi-center trial to measure if postoperative pain and the amount of narcotics used are reduced by a clinically significant amount in women undergoing minimally invasive hysterectomy receiving a continuous infusion of intraperitoneal (IP) local anesthetic (LA) or a continuous infusion of LA combined with an NSAID compared with a control group who receives only 0.9% normal saline.

Being studied: Ropivacaine Infusion from ON-Q Pump; Ropivacaine + Ketorolac Infusion from ON-Q Pump; Normal Saline Infusion from ON-Q Pump

Conditions: Hysterectomy; Gynecologic Surgical Procedures; Narcotic Use; Pain, Postoperative

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Hysterectomy planned for a benign gynecologic reason (no evidence of, or concern for, malignancy in the cervix, uterus, tubes or ovaries. Benign gynecologic reasons to have a hysterectomy include fibroids, abnormal uterine bleeding, endometriosis, and pelvic pain.)
  • Patient is scheduled to have surgery with a fellowship trained minimally invasive gynecologic surgeons at one of the study sites.
  • Patient is planned for a robotic assisted total laparoscopic hysterectomy (RA-TLH) or a total laparoscopic hysterectomy (TLH).
  • Patient is capable of informed consent.
  • Patient is capable of completing the questionnaires.

Exclusion Criteria

  • Concern for malignancy
  • The procedure is scheduled outside MIGS department.
  • Allergy to any study related medication (i.e. Ketorolac and Ropivacaine)
  • Patient is enrolled in another pain management study.

Recruiting US locations

  • MedStar Washington Hospital Center

    Washington D.C., DC 20010

    Site contact: James Robinson, MD · 202-877-0526 · james.k.robinson@medstar.net

  • The GW Medical Faculty Associates

    Washington D.C., DC 20037

    Site contact: Jennifer Keller, MD · 202 741 2524 · jkeller@mfa.gwu.edu

Study contacts (from the official record)

  • Radwa Aly · 202 677 6209 · raly@mfa.gwu.edu
All pain studies in District of Columbia →
Intraperitoneal Infusion of Analgesic for Postoperative Pain… (NCT04130464) | Bored Studies